Repurposing Carfilzomib as a Promising Drug for Targeted Therapy in Gastric Cancer.

Cancers (Basel) · 2025 · PMC12609612 · PMID 41228214

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Moreover, only the combination group showed significantly high levels of apoptosis, though the carfilzomib group showed elevated levels that did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.